Targeted Therapy Cost in India
Compare cost by cancer type and drug class, understand what genetic testing is needed, and get a free personalised estimate within 48 hours.
Top Hospitals
for Targeted Therapy
Find accredited cancer centres with molecular diagnostics labs and precision oncology programs.
Explore Hospitals →Top Doctors
for Targeted Therapy
Connect with internationally trained medical oncologists experienced in precision, biomarker-guided treatment.
Find Doctors →The targeted therapy cost in India ranges from $1,900 to $12,000 per cycle or month, depending on cancer type and drug. Breast cancer targeted therapy costs $2,000-$5,000, lung cancer $3,000-$6,000, CML $1,900-$3,500, colorectal cancer $2,500-$5,500, and kidney cancer $3,000-$6,000 — unlike chemotherapy, treatment is often continued for months or years.
| Treatment Information | Details |
|---|---|
| Treatment Type | Precision Cancer Treatment (Molecular Target-Based) |
| Treatment Name | Targeted Therapy (Oral, Injectable, or IV Infusion) |
| Duration | Ongoing — Months to Years, Depending on Response |
| Treated By | Medical Oncologist |
Targeted Therapy Cost in India — Overview
The targeted therapy cost in India typically ranges from $1,900 to $12,000 per cycle or month, making India one of the most affordable destinations globally for this precision approach to cancer treatment. The targeted therapy price in India depends heavily on the specific drug prescribed, the cancer type and its molecular profile, and whether a generic or biosimilar alternative is available.
Targeted therapy works by identifying and attacking specific genes, proteins, or molecules responsible for cancer growth, unlike traditional chemotherapy which affects healthy and cancerous cells alike. This precision often means fewer side effects and better outcomes for cancers with an identifiable molecular target — but it also means the targeted therapy treatment cost in India depends on confirming that target through genetic testing first.
Targeted Therapy Cost in India for Cancer, by Type
| Cancer Type | Example Drug Class | Approx. Cost Per Cycle/Month (USD) |
|---|---|---|
| Chronic Myeloid Leukemia (CML) | Imatinib-based (BCR-ABL inhibitors) | $1,900 – $3,500 |
| Breast Cancer (HER2-Positive) | Trastuzumab, Pertuzumab | $2,000 – $5,000 |
| Colorectal Cancer | EGFR Inhibitors | $2,500 – $5,500 |
| Lung Cancer (EGFR/ALK-Positive) | Osimertinib, Alectinib | $3,000 – $6,000 |
| Kidney (Renal) Cancer | Tyrosine Kinase Inhibitors | $3,000 – $6,000 |
*Figures are indicative starting estimates. Your exact targeted therapy cost in India depends on your case — request a personalised quote after sharing your reports.
Why Genetic Testing Comes First
Targeted therapy only works on cancers with specific mutations or molecular markers — so before starting treatment, your oncologist will order genetic or biomarker testing to confirm you're a suitable candidate. This precision in patient selection is a key reason targeted cancer therapy cost in India delivers strong outcomes: only patients likely to benefit from a specific drug receive it, reducing trial-and-error treatment.
How Targeted Therapy Is Given
- Oral drugs — many targeted therapies are convenient daily pills taken at home
- Subcutaneous injection — some drugs are given as a shot beneath the skin
- IV infusion — other targeted drugs, especially antibody-based treatments, are given intravenously on an outpatient basis
Treatment schedules vary widely — daily, weekly, or monthly — depending on the specific drug and how your cancer responds. Unlike chemotherapy's fixed number of cycles, targeted therapy is often continued for months or years as long as it remains effective and side effects stay manageable.
Why the Targeted Therapy Price in India Is Lower
India is a global hub for producing high-quality generic and biosimilar versions of targeted therapy drugs like trastuzumab and imatinib, at a fraction of Western branded prices. Combined with government-approved pricing caps on many life-saving cancer drugs and lower hospital operating costs, this makes the targeted therapy cost in India significantly more affordable without compromising on drug quality or oncologist expertise.
Indian hospitals also typically begin treatment immediately after diagnosis, unlike public healthcare systems abroad where patients may wait months for therapy approval.
Targeted Therapy Cost in India vs Other Countries
Targeted therapy drugs are priced globally at a premium wherever they're sold, but India's combination of generic manufacturing and lower hospital overheads keeps the gap especially wide compared to Western markets:
| Country | Approx. Cost Per Cycle/Month (USD) |
|---|---|
| India | $1,900 – $12,000 |
| Turkey | $6,000 – $15,000 |
| United Kingdom | $8,000 – $18,000 |
| United States | $12,000 – $30,000+ |
Targeted Therapy Cost Comparison Across Indian Cities
Pricing also varies somewhat between India's major treatment hubs, largely driven by differences in hospital infrastructure, availability of specialist oncologists, and local operating costs. As a general per-cycle/month reference:
| City | Approx. Cost Per Cycle/Month (USD) |
|---|---|
| Mumbai | $2,200 – $12,500 |
| Delhi NCR | $1,900 – $12,000 |
| Bengaluru | $1,900 – $11,500 |
| Chennai | $1,800 – $11,000 |
| Kolkata | $1,700 – $10,500 |
These figures are a general guide rather than a fixed quote — within any city, the specific drug (generic vs. branded), cancer type, and hospital tier chosen will still have a bigger impact on your final cost than the city itself.
Factors Affecting Targeted Therapy Cost in India
- Cancer type and molecular profile — different mutations require different targeted drugs
- Drug choice — generic/biosimilar vs. branded originator drugs
- Duration of treatment — targeted therapy is often continued long-term
- Combination treatment — used alongside chemotherapy, radiation therapy, or immunotherapy in some cases
- Genetic testing — required upfront to confirm eligibility
- Hospital and city — accreditation level and local pricing
Targeted Therapy Side Effects
Side effects vary by drug but commonly include fatigue, skin or nail changes, high blood pressure, and diarrhoea. According to the National Cancer Institute, targeted therapy side effects are generally different from — and often milder than — those of chemotherapy, since these drugs are designed to affect cancer cells more precisely than healthy tissue.
Top Hospitals and Clinics in India for Targeted Therapy
Most of India's leading precision-oncology centres hold NABH, NABL, or JCI accreditation, backed by dedicated molecular diagnostics labs capable of the genetic and biomarker testing that targeted therapy depends on. This accreditation reflects independently audited standards for both diagnostic accuracy and treatment safety.
What sets these hospitals apart is the depth of experience their medical oncology teams bring to biomarker-guided treatment planning — matching patients to the right targeted drug based on molecular test results, rather than a one-size-fits-all approach. This gives international patients access to genuinely specialised precision oncology care. You can explore Azzocare's network of accredited hospitals to find a centre suited to your specific cancer type and treatment needs.
How Azzocare Helps International Patients
Azzocare connects international patients with verified medical oncologists and JCI-accredited cancer centres across Delhi NCR, managing every step at no extra cost:
- Free medical opinion and itemised cost estimate within 48 hours of sharing your reports
- Medical visa documentation and travel planning support
- Airport pickup and accommodation arranged near your hospital
- Interpreter support throughout consultations and treatment setup
- A dedicated case manager from first contact through ongoing follow-up
Whether you're comparing the targeted therapy cost in India for cancer across hospitals or ready to start genetic testing, our care team can shortlist the right hospital and oncologist for your case before you travel.
Frequently Asked Questions
What is the targeted therapy cost in India?
The targeted therapy cost in India typically ranges from $1,900 to $12,000 per cycle or month, depending on the cancer type, the specific drug used, and whether it's a generic or branded biologic.
What is the targeted therapy cost in India for cancer by type?
Targeted therapy cost in India for cancer varies by type: breast cancer (HER2-targeted) $2,000-$5,000 per cycle, lung cancer (EGFR/ALK inhibitors) $3,000-$6,000, CML (imatinib-based) $1,900-$3,500, colorectal cancer $2,500-$5,500, and kidney cancer $3,000-$6,000 per month.
How long does targeted cancer therapy cost in India continue for?
Unlike chemotherapy's fixed number of cycles, targeted therapy is often ongoing — daily oral drugs or periodic infusions continued for months or years as long as the cancer responds and side effects remain manageable.
Why is targeted therapy price in India higher than chemotherapy?
Targeted therapy drugs are complex biologics designed to attack specific molecular targets on cancer cells, making them more expensive to manufacture than conventional chemotherapy drugs, even though the overall targeted therapy cost in India remains far lower than in Western countries.
What is included in the targeted therapy treatment cost in India?
Standard pricing typically includes the targeted drug itself, oncologist consultation, and administration if given by infusion. Genetic/molecular testing to confirm eligibility, routine monitoring blood work, and imaging scans are often billed separately.
Do I need genetic testing before starting targeted therapy?
Yes. Targeted therapy only works on cancers with specific genetic mutations or molecular markers, so genetic or biomarker testing is required beforehand to confirm you're a suitable candidate for a particular targeted drug.
Is generic targeted therapy available in India?
Yes. India produces generic and biosimilar versions of many targeted therapy drugs, including trastuzumab and imatinib, at significantly lower cost than branded originals while meeting the same quality and effectiveness standards.
Can I get a targeted therapy cost estimate before travelling to India?
Yes. Share your diagnosis, biopsy report, and genetic/molecular test results (if available) with Azzocare's care team, and our oncology panel sends a free, itemised cost estimate — usually within 48 hours.
How is targeted therapy administered?
Targeted therapy can be given as a daily oral pill, a subcutaneous injection, or an intravenous infusion, depending on the specific drug. Many targeted therapies are convenient oral medications taken at home between check-ups.
What side effects can occur with targeted therapy?
Side effects vary by drug but commonly include fatigue, skin or nail changes, high blood pressure, and diarrhoea. Side effects are generally different from — and often milder than — those of chemotherapy, and most improve over time or with dose adjustment.
How long do international patients need to stay in India for targeted therapy?
Since targeted therapy is often taken as an oral medication continued long-term, many international patients stay for the initial consultation, testing, and treatment setup (1-2 weeks), then continue treatment with periodic remote follow-ups.
Does Azzocare charge for arranging targeted therapy in India?
No. All of Azzocare's services — medical opinion, cost estimate, visa assistance, airport pickup, and case coordination — are completely free for patients. You only pay the hospital's standard treatment cost.
What Our Patients Say
Real experiences from patients who received targeted therapy through Azzocare.
My HER2-positive breast cancer responded well to trastuzumab. The generic version cost a fraction of what I was quoted back home, same drug, same effect.
CML managed with imatinib for three years now, mostly through remote follow-ups after my initial visit. Turned what scared me into a manageable routine.
Genetic testing confirmed my EGFR mutation before we even discussed cost. Knowing osimertinib would actually work made the treatment decision straightforward.
Kidney cancer treatment with a TKI drug meant daily pills, not repeated hospital visits. Much easier to manage while still living my life normally.
Compared branded vs generic pricing with my oncologist before deciding. The savings on the generic option meant we could continue treatment much longer.
Colorectal cancer with the right marker meant EGFR-targeted treatment was an option. Grateful the testing was explained clearly before we committed to anything.
Related Pages
Legal Disclaimer
The costs mentioned on this page are approximate figures based on typical targeted therapy pricing ranges in India for 2026. Actual pricing depends on the hospital chosen, the city, the specific drug and cancer type, and each patient's individual medical needs. For an accurate, personalised estimate, please consult your oncologist or reach out to our care team directly.